BALYASNY ASSET MANAGEMENT L.P. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$26,586
-99.0%
762
-98.5%
0.00%
-100.0%
Q3 2022$2,781,000
-10.5%
49,689
+28.3%
0.01%
-40.0%
Q1 2021$3,107,000
-31.4%
38,720
-53.5%
0.02%
-40.0%
Q4 2020$4,526,000
+382.5%
83,193
+45.1%
0.02%
+316.7%
Q2 2019$938,000
+20.3%
57,321
+25.6%
0.01%
+20.0%
Q1 2019$780,000
+21.9%
45,646
-2.7%
0.01%0.0%
Q4 2018$640,00046,9110.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders